These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10952156)

  • 1. G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II.
    Nozato T; Ito H; Tamamori M; Adachi S; Abe S; Marumo F; Hiroe M
    Jpn Circ J; 2000 Aug; 64(8):595-601. PubMed ID: 10952156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes.
    Sadoshima J; Aoki H; Izumo S
    Circ Res; 1997 Feb; 80(2):228-41. PubMed ID: 9012745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
    Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
    J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells.
    Terada Y; Inoshita S; Nakashima O; Tamamori M; Ito H; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Aug; 56(2):494-501. PubMed ID: 10432388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells.
    Yamato K; Koseki T; Ohguchi M; Kizaki M; Ikeda Y; Nishihara T
    Mol Endocrinol; 1997 Jul; 11(8):1044-52. PubMed ID: 9212052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of p27kip1 levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells.
    Rao GN
    Biochim Biophys Acta; 1999 Jan; 1448(3):525-32. PubMed ID: 9990305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes.
    Hauck L; Hansmann G; Dietz R; von Harsdorf R
    Circ Res; 2002 Nov; 91(9):782-9. PubMed ID: 12411392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy.
    Sadoshima J; Izumo S
    Circ Res; 1995 Dec; 77(6):1040-52. PubMed ID: 7586215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cdk Inhibitor p16INK4a by adenovirus vector inhibits cardiac hypertrophy in vitro and in vivo: a novel strategy for the gene therapy of cardiac hypertrophy.
    Nozato T; Ito H; Watanabe M; Ono Y; Adachi S; Tanaka H; Hiroe M; Sunamori M; Marum F
    J Mol Cell Cardiol; 2001 Aug; 33(8):1493-504. PubMed ID: 11448137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
    Aoki H; Richmond M; Izumo S; Sadoshima J
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy.
    Poolman RA; Brooks G
    J Mol Cell Cardiol; 1998 Oct; 30(10):2121-35. PubMed ID: 9799664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arresting developments in the cardiac myocyte cell cycle: role of cyclin-dependent kinase inhibitors.
    Brooks G; Poolman RA; Li JM
    Cardiovasc Res; 1998 Aug; 39(2):301-11. PubMed ID: 9798515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
    Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation.
    Akiyama T; Sugiyama K; Shimizu M; Tamaoki T; Akinaga S
    Jpn J Cancer Res; 1999 Dec; 90(12):1364-72. PubMed ID: 10665655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro.
    Busk PK; Bartkova J; Strøm CC; Wulf-Andersen L; Hinrichsen R; Christoffersen TE; Latella L; Bartek J; Haunsø S; Sheikh SP
    Cardiovasc Res; 2002 Oct; 56(1):64-75. PubMed ID: 12237167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.